Rhythm Pharmaceuticals Inc. (RYTM)
NASDAQ · Healthcare
Rhythm Pharmaceuticals Inc. EBITDA 2016–2025
Rhythm Pharmaceuticals Inc. annual/quarterly ebitda history and growth rate from 2016 to 2021. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Rhythm Pharmaceuticals Inc. ebitda for the quarter ending March 31, 2021 was -34.2 M.
- Rhythm Pharmaceuticals Inc. annual ebitda for 2025 was -191.5 M, a 27.68% decrease from 2024.
- Rhythm Pharmaceuticals Inc. annual ebitda for 2024 was -264.8 M, a 44.34% increase from 2023.
- Rhythm Pharmaceuticals Inc. annual ebitda for 2023 was -183.5 M, a 2.91% increase from 2022.
- Rhythm Pharmaceuticals Inc. annual ebitda for 2022 was -178.3 M.
EBITDA
QUARTERLY · $B
Rhythm Pharmaceuticals Inc. EBITDA — FAQ
Rhythm Pharmaceuticals Inc. (RYTM) ebitda over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RYTM's ebitda history?
The chart and table above show Rhythm Pharmaceuticals Inc.'s ebitda by year and by quarter, including the growth rate.